Prevalence - Impact on P&R Decison? - pharmaLevers

Go to content

Prevalence - Impact on P&R Decison?

Academy > Pricing & Economics
Please see Privacy Policy
Prevalence - Impact on P&R Decison? Swiss Payer RWD - is there a prevalence dependence of the best selling drugs?

This NEWSLETTER examines whether associations can be found between drug sales, treatment costs per patient and treatment prevalence for the best-selling Swiss medicines for 2019.
Back to content